Since PRKRA is known to play a role in antiviral response (Vaughn et al., 2022), perhaps our observations of high levels of CHROMR in glioma could play a role in inhibiting PRKRA related antiviral (which is related to anti-tumor) response. The gene discussed is CHROMR; the disease is neoplasm.